Holen Sie sich die Stockscreener-App
9.27
0.11%
0.010
Schlusskurs vom Vortag:
$9.26
Offen:
$9.26
24-Stunden-Volumen:
1.14M
Relative Volume:
0.86
Marktkapitalisierung:
$823.22M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-4.12
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
-8.85%
1M Leistung:
+7.42%
6M Leistung:
+67.63%
1J Leistung:
+144.59%
1-Tages-Spanne:
$9.0889
$9.54
1-Wochen-Bereich:
$9.0889
$10.48
52-Wochen-Spanne:
$2.8262
$11.40
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
9.27 | 822.33M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-03-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Is Personalis Inc 04X a good long term investmentResistance Breakout Alerts & Free Risk Assessment and Control - earlytimes.in
Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable - 富途牛牛
Personalis (NASDAQ:PSNL) Stock Price Down 4.8%What's Next? - MarketBeat
Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen - MarketBeat
Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize
Is Personalis Inc. (04X) stock undervalued by metricsEarnings Miss & Short-Term High Return Strategies - Newser
Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL - MarketBeat
Will Personalis Inc. (04X) stock maintain strong growthWeekly Volume Report & Growth Focused Investment Plans - Newser
Will Personalis Inc. (04X) stock beat Nasdaq index returns2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Will Personalis Inc. (04X) stock outperform Dow JonesMarket Risk Summary & Fast Moving Market Watchlists - Newser
How Personalis Inc. stock performs during Fed tightening cycles2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Will Personalis Inc. stock reach Wall Street targetsInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus
Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
Morgan Stanley Raises Price Target on Personalis to $11 From $9, Keeps Equalweight Rating - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Dyadic International (DYAI) and NeurAxis, Inc. (NRXS) - The Globe and Mail
Piper Sandler Healthcare Conference - MarketScreener
Personalis Announces $100M Stock Offering Amendment - The Globe and Mail
Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells 103,668 Shares of Stock - MarketBeat
Personalis files prospectus supplement for up to $100 million stock offering - Investing.com Nigeria
Personalis files prospectus supplement for up to $100 million stock offering By Investing.com - Investing.com South Africa
Personalis, Inc. Announces $100 Million Stock Offering - TradingView
Personalis CFO and COO Aaron Tachibana Sells Over 100K Shares - TradingView
COO Tachibana Sells 103,668 ($1.1M) Of Personalis Inc [PSNL] - TradingView
Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st
Personalis Stock: A Growth Inflection Is Imminent (NASDAQ:PSNL) - Seeking Alpha
Personalis (NASDAQ:PSNL) Hits New 12-Month HighHere's What Happened - MarketBeat
Personalis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
COO Tachibana Files To Sell 103,668 Of Personalis Inc [PSNL] - TradingView
Personalis says CMS revises reimbursement rate for Personal test for post-treatment surveillance of cancers - marketscreener.com
Personalis Says CMS Revises Reimbursement Rate For Personal Test For Post-Treatment Surveillance Of Cancers - TradingView
Personalis receives updated Medicare reimbursement rates for cancer monitoring tests - Investing.com India
Personalis, Inc. Announces Revised Medicare Reimbursement Rates - TradingView
[8-K] Personalis, Inc. Reports Material Event | PSNL SEC FilingForm 8-K - Stock Titan
How Analyst Views Are Shifting as Personalis Transforms Its Growth Story - Yahoo Finance
Personalis Inc buy BiotechBee - sharewise.com
BTIG Maintains Personalis (PSNL) Buy Recommendation - MSN
Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 68,679 Personalis, Inc. $PSNL - MarketBeat
Will Personalis Inc. stock recover faster than marketWeekly Profit Report & Fast Moving Market Watchlists - newser.com
Why retail investors favor Personalis Inc. stockJuly 2025 WrapUp & Fast Gain Swing Alerts - newser.com
Can Personalis Inc. stock resist market sell offsLong Setup & Free Technical Confirmation Trade Alerts - newser.com
Will Personalis Inc. (04X) stock benefit from Fed rate cuts2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):